Protective potentials of a plant extract (Lycopodium clavatum) on mice chronically fed hepato-carcinogens

Indian Journal of Experimental Biology

Volumn 47, Issue 7, 2009, Pages 602-607

  Pathak, Surajit ^a   Banerjee, Antara ^a   Paul, Saili ^a   Khuda Bukhsh, Anisur Rahman ^a,b  

^a UNIVERSITY OF KALYANI   (India)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Acid and alkaline phosphatase; Hepatoprotective; Lycopodium clavatum; P dimethyl aminoazobenzene; Phenobarbital

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; CARCINOGEN; GLUTATHIONE REDUCTASE; PLANT EXTRACT; SUCCINATE DEHYDROGENASE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; LIVER; LIVER TUMOR; LYCOPODIUM; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYTOTHERAPY; TRADITIONAL MEDICINE;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANIMALS; CARCINOGENS; FEMALE; GLUTATHIONE REDUCTASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; LYCOPODIUM; MALE; MEDICINE, TRADITIONAL; MICE; PHYTOTHERAPY; PLANT EXTRACTS; SUCCINATE DEHYDROGENASE;

BACTERIA (MICROORGANISMS); LYCOPODIUM; LYCOPODIUM CLAVATUM; MUS;

EID: 70349329862     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. International Agency for Research on Cancer (IARC), On the evaluation of carcinogenic risk of chemicals to man, Group 2B, supplement 7, (1987) 440.
2. (Pubitemid 17215638) Nesnow S, Argus M, Bergman H, Chu K, Frith C, Helmes T, Mcgaughy R, Ray V, Slaga T J, Tennant R & Weisburger E, Chemical carcinogenesis: A review and analysis of the literature of selected chemicals and the establishment of the gene-tox carcinogen database: A report of the US. Environmental Protection Agency gen-tox program, Mutat Res, 185 (1987) 1.
3. (Pubitemid 32409692) Tsuda S, Murakami M, Matsusaka N, Kano K, Taniguchi K & Sasaki YF, DNA damage induced by red food dyes orally administered to pregnant and male mice, Toxicol Sci, 361 (2001) 92.
4. International Agency for Research on Cancer (IARC), Summaries and Evaluations, Phenobarbital and its sodium salt, Group 2B, 79 (2001) 161.
5. (Pubitemid 9090421) Kitagawa T, Pitot H C, Miller E C & Miller J A, Promotion by dietary phenobarbital of hepatocarcinogenesis by 2- methyl-N, N-dimethyl-4-aminoazobenzene in the rat, Cancer Res, 39 (1979) 112.
6. (Pubitemid 8111861) Kitagawa T & Sugano H, Enhancement of azodye hepatocarcinogenesis with dietary phenobarbital in rats, Gann, 68 (1977) 255.
7. Murray G I, The role of cytochrome P450 in tumour development and progression and its potential in therapy, J Pathol, 192 (4) (2000) 419.
8. (Pubitemid 39504754) Biswas S J, Pathak S & Khuda-Bukhsh A R, Assessment of the genotoxic and cytotoxic potential of an anti-epileptic drug, phenobarbital, in mice: A time course study, Mutat Res, 563 (2004) 1.
9. (Pubitemid 46842956) Pathak S & Khuda-Bukhsh A R, Assessment of hepatocellular damage and hematological alterations in mice chronically fed p-dimethyl aminoazobenzene and phenobarbital, Exp Mol Pathol, 83 (2007) 104.
10. Simpson C A, Complementary medicine in chronic pain treatment. Phys Med Rehabil Clin N Am, 17 (2) (2006) 451.
11. (Pubitemid 40528813) Hana G, Bar-Sela G, Zhana D, Mashiach T & Robinson E, The use of complementary and alternative therapies by cancer patients in northern Israel, Isr Med Assoc J, 7 (2005) 243.
12. th edition, (Sett Dey and Co, Calcutta, India) 1992, 409.
13. Gebhardt R, Antioxidative, antiproliferative and biochemical effects in HepG2 cells of a homeopathic remedy and its constituent plant tinctures tested separately or in combination, Arzneimittelforschung, 53 (12) (2003) 823.
14. Es S, Kuttan G, Kc P & Kuttan R, Effect of homeopathic medicines on transplanted tumors in mice, Asian Pac J Cancer Prev, 8 (3) (2007) 390.
15. Daoust R, The mitotic activity in rat liver during DAB carcinogenesis, Cancer Res, 22 (1962) 743.
16. Daoust R & Molnar F, Cellular population and mitotic activity in pre neoplastic liver parenchyma, Proc Am Assoc Cancer Res, 4 (1963) 13.
17. Daoust R & Cantero A, The numerical proportions of cell types in rat liver during carcinogenesis by 4- dimethylaminoazobenzene, Cancer Res, 19 (1959) 757.
18. Palekar S D & Sirsat S M, Studies on hepatocyte in azo dye carcinogenesis, Indian J Exp Biol, 4 (1966) 73.
19. Biswas S J & Khuda-Bukhsh A R, Cytotoxic and genotoxic effects of the azo-dye p-dimethylaminoazobenzene in mice: A time-course study, Mutat Res, 587 (2005) 1.
20. (Pubitemid 47013382) Pathak S, Bhattacharjee N, Das J K, Choudhury S C, Karmakar S R, Banerjee P, Paul S, Banerjee A & Khuda- Bukhsh A R, Supportive evidences for anti-cancerous potential of an alternative medicine in hepatocarcinogenesis of mice, Forsch Komplementarmed, 14 (2007) 148.
21. Pathak S, Das J K, Biswas S J & Khuda-Bukhsh A R, Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice, Mol Cell Biochem, 285 (2006) 121.
22. Lowry O H, Rosebrough N J, Farr A L & Randall R J, Protein measurement with Folin-Phenol reagent, J Biol Chem, 193 (1951) 265.
23. Walter K & Schutt C, Acid and alkaline phosphatase in serum (Two point method) in Methods in enzymatic analysis, edited by H U Bergmeyer, (Academic Press, New York, USA) 1974, 856.
24. Beutler E, Red cell metabolism - Manual of biochemical methods. (Grune and Stratton, New York) 1975, 69.
25. Slater E C & Bonner W D, The effect of fluoride on succinic oxidase system, Biochemical J, 52 (1952) 185.
26. rd edition, (Tata McGraw-Hill Publication Company Ltd, New Delhi) 1988, 197.
27. th edition, (Pergamon Press, Oxford) 1991, 55.
28. Timbrell J A, Principles of biochemical toxicology. (Taylor and Francis, London). 1991.
29. Vinitha R, Thangaraju M & Sachdanandam P, Effect of administering cyclophosphamide and vitamin E on the levels of tumor-marker enzymes in rats with experimentally induced fibrosarcoma, Japan J Med Sci Biol, 48 (1995) 145.
30. Beutler E & Yeh M K Y, Erythrocyte glutathione reductase, Blood, 5 (1963) 573.
31. Warsy A S & El-Hazmi M A F, Glutathione reductase deficiency in Saudi Arabia, Eastern Mediterranean Health J, 6 (1999) 1208.
32. Hederstedt L & Rutberg L, Succinate dehydrogenase - A comparative review, Microbiol Rev, 45 (1981) 542.
33. Kuper H, Mantzoros C, Lagiou P, Tzonou A, Tamimi A, Mucci L, Benetou L, Spanos E, Stuver S & Trichopoulos D, Estrogens, Testosterone and Sex Hormone Binding Globulin in relation to liver cancer in men, Oncology, 60 (2001) 355.
34. (Pubitemid 39099797) Zhang K & Chow P K H, The effect of Megestrol Acetate on growth of HepG2 cells in vitro and in vivo, Clin Cancer Res, 10 (2004) 5226.
35. Cauley J A, Lucas F L, Kuller L H, Stone K, Browner W & Cummings S R, Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer: Study of Osteoporotic Fractures Research Group, Ann Intern Med, 130 (1999) 270.
36. Yamamoto R, Iishi H, Tatsuta M, Tsuji M & Terada N, Roles of ovaries and testes in hepatocellular tumorigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene, Int J Cancer, 49 (1) (1991) 83.
37. (Pubitemid 23349793) Yamamoto R, Iishi H, Tatsuta M, Tsuji M & Terada N, Suppressive effect of estrogen on hepatocellular tumorigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene, Exp Toxicol Pathol, 45 (1993) 325.
38. Tsutsui S, Yamamoto R, Iishi H, Tatsuta M, Tsuji M & Terada N, Promoting effect of ovariectomy on hepatocellular tumorigenesis induced in mice by 3'-methyl-4- dimethylaminoazobenzene, Virchows Arch B cell Pathol Incl Mol Pathol, 62 (1992) 371.